Adam Paxton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adam Paxton has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Vikren Sarkar
Department of Radiation Oncology, The University of Utah, Salt Lake City, UT 84112, United States of America
6 shared publications Bill Salter
Univ Utah, Dept Radiat Oncol, 1950 Circle Hope, Salt Lake City, UT 84112 USA
4 shared publications- Ryan Price
Department of Radiation Oncology, Huntsman Cancer Hospital University of Utah Salt Lake City, Utah USA
4 shared publications Fan‐Chi Frances Su
University of Texas Southwestern Dallas Texas USA
2 shared publications- Geoff Nelson
Department of Radiation Oncology University of Utah Salt Lake City Utah USA
2 shared publications - Hui Zhao
Department of Radiation Oncology, Huntsman Cancer Hospital University of Utah Salt Lake City, Utah USA
2 shared publications
Latest Publications
- Open Access
- 27 January 2026
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 27 (2) , e70475
Evaluation of medical physics resident well‐being and satisfaction across multiple residency programs
A resident satisfaction and well‐being survey was developed and administered within a Multi‐Institutional Journal Club (MIJC) including therapy medical physics residency programs within the Karmanos Cancer Institute, the University of Maryland, the University of Utah, and the University of Alabama‐Birmingham. The survey was designed as a tool for quality improvement and program evaluation within each individual program. Survey items were derived in part from existing well‐established question inventories and included 26 questions, 4 of which were derived from the Maslach Burnout Inventory (MBI) and 12 from the American Psychological Association Work and Well‐being Survey. The survey was administered anonymously via email link annually from 2022 to 2025, and 41 residents responded to the survey during this period. Mean Likert scores for positively keyed survey items (higher score is better) ranged from 4.00/5 to 4.78/5. Mean Likert scores for negatively keyed survey items (lower score is better) ranged from 1.37/5 to 2.71/5. Items were subsequently grouped into five themes: “Burnout,” “Work‐Life Balance,” “Interpersonal Relationships,” “Institutional Values,” and “Job Satisfaction.” Mean scores for these themes were universally positive and ranged from 4.55/5 for “Job Satisfaction” to 3.63/5 for “Work‐Life Balance.” For the “Interpersonal Relationships,” “Institutional Values,” and “Job Satisfaction” themes, 11 of 12 survey items had a median Likert score of 5/5. No respondent indicated a Likert score under ‘3’ for any of the items in the “Job Satisfaction” theme, making it the most consistently positive theme of the survey. Free‐text comments were categorized as “Positive,” “Neutral,” or “Negative.” Of 70 total free‐text comments, 25 (36%) were categorized as “Positive,” 39 (56%) as “Neutral” and 6 (9%) as “Negative.” Approximately 20% of respondents felt a strong sense of burnout or emotional exhaustion. However, nearly 90% felt that their program and program faculty made them feel valued and that they would recommend their residency program to trainees looking for a position. These results compare favorably with previously published data for radiation oncology residents and represent a strong positive sentiment about the characteristics of these residency programs and the residency process itself. While stress and difficulties maintaining work/life balance were clearly acknowledged, quantitative and free‐text comments indicate that the positive aspects of residency training substantially outweigh these negative aspects. The survey has provided a substantial amount of information supporting the success and best practices involved in our programs as well as some constructive negative feedback, which can allow us to further improve our respective programs and potentially serve as a model to help improve medical physics residency training throughout our profession.
- 27 January 2026
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 27 (2) , e70475
Open AccessEvaluation of medical physics resident well‐being and satisfaction across multiple residency programs
A resident satisfaction and well‐being survey was developed and administered within a Multi‐Institutional Journal Club (MIJC) including therapy medical physics residency programs within the Karmanos Cancer Institute, the University of Maryland, the University of Utah, and the University of Alabama‐Birmingham. The survey was designed as a tool for quality improvement and program evaluation within each individual program. Survey items were derived in part from existing well‐established question inventories and included 26 questions, 4 of which were derived from the Maslach Burnout Inventory (MBI) and 12 from the American Psychological Association Work and Well‐being Survey. The survey was administered anonymously via email link annually from 2022 to 2025, and 41 residents responded to the survey during this period. Mean Likert scores for positively keyed survey items (higher score is better) ranged from 4.00/5 to 4.78/5. Mean Likert scores for negatively keyed survey items (lower score is better) ranged from 1.37/5 to 2.71/5. Items were subsequently grouped into five themes: “Burnout,” “Work‐Life Balance,” “Interpersonal Relationships,” “Institutional Values,” and “Job Satisfaction.” Mean scores for these themes were universally positive and ranged from 4.55/5 for “Job Satisfaction” to 3.63/5 for “Work‐Life Balance.” For the “Interpersonal Relationships,” “Institutional Values,” and “Job Satisfaction” themes, 11 of 12 survey items had a median Likert score of 5/5. No respondent indicated a Likert score under ‘3’ for any of the items in the “Job Satisfaction” theme, making it the most consistently positive theme of the survey. Free‐text comments were categorized as “Positive,” “Neutral,” or “Negative.” Of 70 total free‐text comments, 25 (36%) were categorized as “Positive,” 39 (56%) as “Neutral” and 6 (9%) as “Negative.” Approximately 20% of respondents felt a strong sense of burnout or emotional exhaustion. However, nearly 90% felt that their program and program faculty made them feel valued and that they would recommend their residency program to trainees looking for a position. These results compare favorably with previously published data for radiation oncology residents and represent a strong positive sentiment about the characteristics of these residency programs and the residency process itself. While stress and difficulties maintaining work/life balance were clearly acknowledged, quantitative and free‐text comments indicate that the positive aspects of residency training substantially outweigh these negative aspects. The survey has provided a substantial amount of information supporting the success and best practices involved in our programs as well as some constructive negative feedback, which can allow us to further improve our respective programs and potentially serve as a model to help improve medical physics residency training throughout our profession.
- 5 June 2024
- Published by Elsevier in Physica Medica
- Vol. 123, 103379
Automation framework for online review of daily dose distributions using CT on Rails in proton therapy
- 5 June 2024
- Published by Elsevier in Physica Medica
- Vol. 123, 103379
Automation framework for online review of daily dose distributions using CT on Rails in proton therapy
- Open Access
- 24 January 2024
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 25 (2) , e14263
Verification of surface‐guided radiation therapy (SGRT) alignment for proton breast and chest wall patients by comparison to CT‐on‐rails and kV‐2D alignment
Background: Surface‐guided radiation therapy (SGRT) systems have been widely installed and utilized on linear accelerators. However, the use of SGRT with proton therapy is still a newly developing field, and published reports are currently very limited.Purpose: To assess the clinical application and alignment agreement of SGRT with CT‐on‐rails (CTOR) and kV‐2D image‐guided radiation therapy (IGRT) for breast treatment using proton therapy.Methods: Four patients receiving breast or chest wall treatment with proton therapy were the subjects of this study. Patient #1′s IGRT modalities were a combination of kV‐2D and CTOR. CTOR was the only imaging modality for patients #2 and #3, and kV‐2D was the only imaging modality for patient #4. The patients’ respiratory motions were assessed using a 2‐min surface position recorded by the SGRT system during treatment. SGRT offsets reported after IGRT shifts were recorded for each fraction of treatment. The agreement between SGRT and either kV‐2D or CTOR was evaluated.Results: The respiratory motion amplitude was ° in rotation for all patients. The mean and maximum amplitude of SGRT offsets after application of IGRT shifts were ≤(2.6 mm, 1.6°) and (6.8 mm, 4.5°) relative to kV‐2D‐based IGRT; ≤(3.0 mm, 2.6°) and (5.0 mm, 4.7°) relative to CTOR‐based IGRT without breast tissue inflammation. For patient #3, breast inflammation was observed for the last three fractions of treatment, and the maximum SGRT offsets post CTOR shifts were up to (14.0 mm, 5.2°).Conclusions: Due to the overall agreement between SGRT and IGRT within reasonable tolerance, SGRT has the potential to serve as a valuable auxiliary IGRT tool for proton breast treatment and may improve the efficiency of proton breast treatment.
- 24 January 2024
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 25 (2) , e14263
Open AccessVerification of surface‐guided radiation therapy (SGRT) alignment for proton breast and chest wall patients by comparison to CT‐on‐rails and kV‐2D alignment
Background: Surface‐guided radiation therapy (SGRT) systems have been widely installed and utilized on linear accelerators. However, the use of SGRT with proton therapy is still a newly developing field, and published reports are currently very limited.Purpose: To assess the clinical application and alignment agreement of SGRT with CT‐on‐rails (CTOR) and kV‐2D image‐guided radiation therapy (IGRT) for breast treatment using proton therapy.Methods: Four patients receiving breast or chest wall treatment with proton therapy were the subjects of this study. Patient #1′s IGRT modalities were a combination of kV‐2D and CTOR. CTOR was the only imaging modality for patients #2 and #3, and kV‐2D was the only imaging modality for patient #4. The patients’ respiratory motions were assessed using a 2‐min surface position recorded by the SGRT system during treatment. SGRT offsets reported after IGRT shifts were recorded for each fraction of treatment. The agreement between SGRT and either kV‐2D or CTOR was evaluated.Results: The respiratory motion amplitude was ° in rotation for all patients. The mean and maximum amplitude of SGRT offsets after application of IGRT shifts were ≤(2.6 mm, 1.6°) and (6.8 mm, 4.5°) relative to kV‐2D‐based IGRT; ≤(3.0 mm, 2.6°) and (5.0 mm, 4.7°) relative to CTOR‐based IGRT without breast tissue inflammation. For patient #3, breast inflammation was observed for the last three fractions of treatment, and the maximum SGRT offsets post CTOR shifts were up to (14.0 mm, 5.2°).Conclusions: Due to the overall agreement between SGRT and IGRT within reasonable tolerance, SGRT has the potential to serve as a valuable auxiliary IGRT tool for proton breast treatment and may improve the efficiency of proton breast treatment.
- Open Access
- 13 November 2023
- Published by Springer Nature in Cureus
- Vol. 15 (11) , e48742
Characterization of an Onboard Transmission Detector for Efficient Linear Accelerator Output Quality Assurance
Purpose To investigate the potential to perform linear accelerator output quality assurance (QA) with the ScandiDos Delta4 Discover (Discover) onboard transmission detector. Materials and methods Using the ScandiDos Delta4 software (version 8), a conversion factor from raw signal to output was obtained via cross-calibration with an accredited dosimetry calibration laboratory (ADCL) calibrated ionization chamber for each photon energy, including flattening-filter-free (FFF) energies. With the calibration factor for 6 MV (6x) photon energy, output measurements were taken with both the Delta4 Discover and ion chamber and compared for output as a function of gantry angle and dose-rate dependence. Monitor unit (MU) linearity for 6x was measured and compared with ion chamber measurements. Additionally, the Discover was used to take output measurements, for 6x, approximately every hour throughout the course of a treatment day, and compared with ion chamber output measurements at the beginning and end of the treatment day. Results Output measurements for each photon energy were comparable with a maximum difference of -0.57% for flattened beams (6x) and 0.21% for FFF beams (10FFF). Output measurements using the Discover matched ion chamber output measurements at every dose rate within 2%, and within 1% for output as a function of gantry angle. MU linearity test agreed with ion chamber measurements with a maximum difference of 0.41%. Output measurements using the Discover showed a daily drift in output throughout the course of a treatment day of around 2% and correlated very well with ion chamber outputs measured at the beginning and end of the treatment day (within 0.2%). Conclusions The ScandiDos Delta4 Discover onboard transmission detector is able to accurately measure linear accelerator output comparable to ion chamber measurements.
- 13 November 2023
- Published by Springer Nature in Cureus
- Vol. 15 (11) , e48742
Open AccessCharacterization of an Onboard Transmission Detector for Efficient Linear Accelerator Output Quality Assurance
Purpose To investigate the potential to perform linear accelerator output quality assurance (QA) with the ScandiDos Delta4 Discover (Discover) onboard transmission detector. Materials and methods Using the ScandiDos Delta4 software (version 8), a conversion factor from raw signal to output was obtained via cross-calibration with an accredited dosimetry calibration laboratory (ADCL) calibrated ionization chamber for each photon energy, including flattening-filter-free (FFF) energies. With the calibration factor for 6 MV (6x) photon energy, output measurements were taken with both the Delta4 Discover and ion chamber and compared for output as a function of gantry angle and dose-rate dependence. Monitor unit (MU) linearity for 6x was measured and compared with ion chamber measurements. Additionally, the Discover was used to take output measurements, for 6x, approximately every hour throughout the course of a treatment day, and compared with ion chamber output measurements at the beginning and end of the treatment day. Results Output measurements for each photon energy were comparable with a maximum difference of -0.57% for flattened beams (6x) and 0.21% for FFF beams (10FFF). Output measurements using the Discover matched ion chamber output measurements at every dose rate within 2%, and within 1% for output as a function of gantry angle. MU linearity test agreed with ion chamber measurements with a maximum difference of 0.41%. Output measurements using the Discover showed a daily drift in output throughout the course of a treatment day of around 2% and correlated very well with ion chamber outputs measured at the beginning and end of the treatment day (within 0.2%). Conclusions The ScandiDos Delta4 Discover onboard transmission detector is able to accurately measure linear accelerator output comparable to ion chamber measurements.
- 29 September 2023
- Published by Elsevier in Physica Medica
- Vol. 114, 103146
Initial clinical evaluation of a novel combined biometric, radio-frequency identification, and surface imaging system
- 29 September 2023
- Published by Elsevier in Physica Medica
- Vol. 114, 103146
Initial clinical evaluation of a novel combined biometric, radio-frequency identification, and surface imaging system
- Open Access
- 12 April 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (5)
Measurements of fetal dose with Mevion S250i proton therapy system with HYPERSCAN
Purpose: To characterize potential dose to the fetus for all modes of delivery (dynamic adaptive aperture, static adaptive aperture, and no adaptive aperture) for the Mevion S250i Proton Therapy System with HYPERSCAN and compare the findings with those of other available proton systems.Materials and Methods: Fetal dose measurements were performed for all three modes of dose delivery on the Mevion S250i Proton therapy system with HYPERSCAN (static aperture, dynamic aperture and uncollimated). Standard treatment plans were created in RayStation for a left‐sided brain lesion treated with a vertex field, a left lateral field, and a posterior field. Measurements were performed using WENDI and the RANDO with the detector placed at representative locations to mimic the growth and movement of the fetus at different gestational stages.Results: The fetal dose measurements varied with fetus position and the largest measured dose was 64.7 μSv per 2 Gy (RBE) fraction using the dynamic aperture. The smallest estimated fetal dose was 45.0 μSv per 2 Gy (RBE) at the base of the RANDO abdomen (47 cm from isocenter to the outer width of WENDI and 58.5 cm from the center of the WENDI detector) for the static aperture delivery. The vertex fields at all depths had larger contributions to the total dose than the other two and the dynamic aperture plans resulted in the highest dose measured for all depths.Conclusion: The reported doses are lower than reported doses using a double‐scattering system. This work suggests that avoiding vertex fields and using the static aperture will help minimize dose to the fetus.
- 12 April 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (5)
Open AccessMeasurements of fetal dose with Mevion S250i proton therapy system with HYPERSCAN
Purpose: To characterize potential dose to the fetus for all modes of delivery (dynamic adaptive aperture, static adaptive aperture, and no adaptive aperture) for the Mevion S250i Proton Therapy System with HYPERSCAN and compare the findings with those of other available proton systems.Materials and Methods: Fetal dose measurements were performed for all three modes of dose delivery on the Mevion S250i Proton therapy system with HYPERSCAN (static aperture, dynamic aperture and uncollimated). Standard treatment plans were created in RayStation for a left‐sided brain lesion treated with a vertex field, a left lateral field, and a posterior field. Measurements were performed using WENDI and the RANDO with the detector placed at representative locations to mimic the growth and movement of the fetus at different gestational stages.Results: The fetal dose measurements varied with fetus position and the largest measured dose was 64.7 μSv per 2 Gy (RBE) fraction using the dynamic aperture. The smallest estimated fetal dose was 45.0 μSv per 2 Gy (RBE) at the base of the RANDO abdomen (47 cm from isocenter to the outer width of WENDI and 58.5 cm from the center of the WENDI detector) for the static aperture delivery. The vertex fields at all depths had larger contributions to the total dose than the other two and the dynamic aperture plans resulted in the highest dose measured for all depths.Conclusion: The reported doses are lower than reported doses using a double‐scattering system. This work suggests that avoiding vertex fields and using the static aperture will help minimize dose to the fetus.
- Open Access
- 10 January 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (5)
An evaluation of the use of DirectSPR images for proton planning in the RayStation treatment planning software
An important source of uncertainty in proton therapy treatment planning is the assignment of stopping‐power ratio (SPR) from CT data. A commercial product is now available that creates an SPR map directly from dual‐energy CT (DECT). This paper investigates the use of this new product in proton treatment planning and compares the results to the current method of assigning SPR based on a single‐energy CT (SECT). Two tissue surrogate phantoms were CT scanned using both techniques. The SPRs derived from single‐energy CT and by DirectSPR™ were compared to measured values. SECT‐based values agreed with measurements within 4% except for low density lung and high density bone, which differed by 13% and 8%, respectively. DirectSPR™ values were within 2% of measured values for all tissues studied. Both methods were also applied to scanned containers of three types of animal tissue, and the expected range of protons of two different energies was calculated in the treatment planning system and compared to the range measured using a multi‐layer ion chamber. The average difference between range measurements and calculations based on SPR maps from dual‐ and single‐energy CT, respectively, was 0.1 mm (0.07%) versus 2.2 mm (1.5%). Finally, a phantom was created using a layer of various tissue surrogate plugs on top of a 2D ion chamber array. Dose measurements on this array were compared to predictions using both single‐ and dual‐energy CTs and SPR maps. While standard gamma pass rates for predictions based on DECT‐derived SPR maps were slightly higher than those based on single‐energy CT, the differences were generally modest for this measurement setup. This study showed that SPR maps created by the commercial product from dual‐energy CT can successfully be used in RayStation to generate proton dose distributions and that these predictions agree well with measurements.
- 10 January 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (5)
Open AccessAn evaluation of the use of DirectSPR images for proton planning in the RayStation treatment planning software
An important source of uncertainty in proton therapy treatment planning is the assignment of stopping‐power ratio (SPR) from CT data. A commercial product is now available that creates an SPR map directly from dual‐energy CT (DECT). This paper investigates the use of this new product in proton treatment planning and compares the results to the current method of assigning SPR based on a single‐energy CT (SECT). Two tissue surrogate phantoms were CT scanned using both techniques. The SPRs derived from single‐energy CT and by DirectSPR™ were compared to measured values. SECT‐based values agreed with measurements within 4% except for low density lung and high density bone, which differed by 13% and 8%, respectively. DirectSPR™ values were within 2% of measured values for all tissues studied. Both methods were also applied to scanned containers of three types of animal tissue, and the expected range of protons of two different energies was calculated in the treatment planning system and compared to the range measured using a multi‐layer ion chamber. The average difference between range measurements and calculations based on SPR maps from dual‐ and single‐energy CT, respectively, was 0.1 mm (0.07%) versus 2.2 mm (1.5%). Finally, a phantom was created using a layer of various tissue surrogate plugs on top of a 2D ion chamber array. Dose measurements on this array were compared to predictions using both single‐ and dual‐energy CTs and SPR maps. While standard gamma pass rates for predictions based on DECT‐derived SPR maps were slightly higher than those based on single‐energy CT, the differences were generally modest for this measurement setup. This study showed that SPR maps created by the commercial product from dual‐energy CT can successfully be used in RayStation to generate proton dose distributions and that these predictions agree well with measurements.